Litigation Note: Crowell & Moring Client Agilent Successfully Rebuts Preliminary Injunction Because Patent Likely Invalid
October 04, 2019
October 04, 2019
NEW YORK, Oct. 4 -- Crowell and Moring, a law firm, issued the following news release:
In October 2018, plaintiff Waters Corporation filed for a preliminary injunction against Crowell & Moring's client, Agilent, for it to cease selling InstantPCTM reagent, which is used during the development of biopharmaceuticals or biologics. Oral arguments were held last December. On Friday, September 20, 2019, the District of Delaware denied Waters' motion for a preliminary injunction.
In October 2018, plaintiff Waters Corporation filed for a preliminary injunction against Crowell & Moring's client, Agilent, for it to cease selling InstantPCTM reagent, which is used during the development of biopharmaceuticals or biologics. Oral arguments were held last December. On Friday, September 20, 2019, the District of Delaware denied Waters' motion for a preliminary injunction.